2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 15:39, 21 November 2023
, 21 November 2023→Potential Benefits
No edit summary |
|||
| Line 126: | Line 126: | ||
| style="vertical-align:top; border:none;" | | | style="vertical-align:top; border:none;" | | ||
* '''Safety''': basically safe under the existing intervention dose and time | * '''Safety''': basically safe under the existing intervention dose and time | ||
* '''Sleep quality''': no significant improvement{{ | * '''Sleep quality''': no significant improvement{{pmid|35215405}} | ||
* '''Physical activity''': prevented aging-related muscle dysfunctions and improving physical performance | * '''Physical activity''': prevented aging-related muscle dysfunctions and improving physical performance{{pmid|35215405}},{{pmid|35927255}},{{pmid|34238308}},{{pmid|35821806}} | ||
* '''Ear''': improved the right auditory ability of old men{{pmid|35927255}} | * '''Ear''': improved the right auditory ability of old men{{pmid|35927255}} | ||
* '''Cognition''': no significant improvement{{pmid|35927255}} | * '''Cognition''': no significant improvement{{pmid|35927255}} | ||
* '''Diabetes''': increased muscle insulin sensitivity, insulin signaling, and remodeling in prediabetic women{{ | * '''Diabetes''': increased muscle insulin sensitivity, insulin signaling, and remodeling in prediabetic women{{pmid|33888596}} | ||
* '''Telomere''': increased telomere length | * '''Telomere''': increased telomere length{{pmid|34912838}} | ||
|} | |} | ||